Narsoplimab Uses, Dosage, Side Effects and more
Narsoplimab is under investigation in clinical trial NCT03205995 (Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome).
| Trade Name | Narsoplimab |
| Generic | Narsoplimab |
| Narsoplimab Other Names | MASP-2 antibody, Narsoplimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
